Trials / Completed
CompletedNCT05372653
A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
A Phase 3, Multicenter, Open-label, Uncontrolled Trial to Evaluate the Efficacy and Safety of OPA-15406 Ointment in Infants Younger Than 2 Years of Age With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 3 Months – 2 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy of 0.3% OPA-15406 ointment when administered twice daily for 4 weeks in infants younger than 2 years of age with Atopic Dermatitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPA-15406 | 0.3% or 1% ointment, topical, twice daily, for 52 weeks |
Timeline
- Start date
- 2022-05-23
- Primary completion
- 2022-12-29
- Completion
- 2023-11-29
- First posted
- 2022-05-13
- Last updated
- 2025-03-30
- Results posted
- 2025-03-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05372653. Inclusion in this directory is not an endorsement.